GeNeuro SA (GEM.F)

1.3650 -0.0350 (-2.50%) As of 08:03AM CEST. Market open.

GeNeuro SA

3 chemin du PrE-Fleuri
Plan-les-Ouates 1228
Switzerland
41 22 552 48 00
https://www.geneuro.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 19

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Jesus Martin-Garcia	Chairman & CEO	652.59k	N/A	1962
Mr. Miguel Payró	Chief Financial Officer	N/A	N/A	1965
Dr. Hervé Perron	Chief Scientific Officer	N/A	N/A	1959
Dr. Alois B. Lang Ph.D.	Chief Development Officer	N/A	N/A	1952
Dr. Anke Post M.D., Ph.D.	Chief Medical Officer	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family; treats type 1 diabetes; and treats chronic inflammatory demyelinating polyneuropathy. It also developing GNK301. In addition, It has cooperative research and development agreements with The National Institute of Neurological Disorders and Stroke to develop novel therapeutic antibodies for the treatment of amyotrophic lateral sclerosis; and Academic centers to develop inflammatory psychosis, as well as a research collaboration agreement with International Center for Infectiology Research; and with Northwestern University for human endogenous retrovirus W envelope protein (HERV-W ENV) in long-haul COVID patients. The company was incorporated in 2006 and is headquartered in Plan-les-Ouates, Switzerland.

Corporate Governance

GeNeuro SA’s ISS Governance QualityScore as of May 1, 2024 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 1; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.